Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Nancy I. Hein"'
Autor:
Mary S. Urcan, Christopher M. Mapes, Marilyn Wardlow, Kathleen M. Ogilvie, Margaret M. Faul, Carol L. Broderick, Jennifer D'Arrigo, Nancy I. Hein, Mark D. Leibowitz, Marcus F. Boehm, Anne Reifel-Miller, Mark A. Carfagna, John S. Tyhonas, Deepa Rungta, Henry Havel, Dale E. Mais, Timothy Alan Grese, Sha Liu, Robert Ardecky, Bernadette Pascual, Keith B. Marschke, Nathan Yumibe, Chahrzad Montrose-Rafizadeh, Kay Klausing, Pierre-Yves Michellys, Diane L. Crombie, Richard A. Heyman, Diane Jolley, Garrett J. Etgen
Publikováno v:
Endocrinology. 147(2)
Specific retinoid X receptor (RXR) agonists, such as LG100268 (LG268), and the thiazolidinedione (TZD) PPARgamma agonists, such as rosiglitazone, produce insulin sensitization in rodent models of insulin resistance and type 2 diabetes. In sharp contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fab886baba55738ba4a10fe45b904a20
https://pubmed.ncbi.nlm.nih.gov/16269450
https://pubmed.ncbi.nlm.nih.gov/16269450
Autor:
Mark D. Leibowitz, Kay Klausing, Bernadette Pascual, Diane Jolley, Mary S. Urcan, Sha Liu, Danmei Li, James M. Bilakovics, Mark A. Lawson, Kathleen M. Ogilvie, Nancy I. Hein
Publikováno v:
Endocrinology. 143(8)
The retinoid X receptor (RXR) agonist bexarotene can cause clinically significant hypothyroidism in cutaneous T cell lymphoma patients. The mechanism by which the RXR agonist produces this effect is unclear. We have studied the impact of a selective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f0e4cc6675c2545e6fdd0214b0df2f7
https://pubmed.ncbi.nlm.nih.gov/12130551
https://pubmed.ncbi.nlm.nih.gov/12130551